Octavus Consulting

𝐇𝐨𝐨𝐫𝐚𝐡 🙌, 𝐢𝐭’𝐬 𝐭𝐢𝐦𝐞 𝐟𝐨𝐫 𝐨𝐮𝐫 𝐃𝐢𝐰𝐚𝐥𝐢 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐫𝐨𝐰𝐛𝐚𝐜𝐤 𝐏𝐢𝐜𝐭𝐮𝐫𝐞𝐬 🖼️! Octavus Consulting embraced the festive vibes of Diwali with great zeal and enthusiasm! Amidst the earthy smell of clay diyas and soothing light emanating from decorative lanterns, we celebrated the essence of Diwali 🧨 a week ahead and gave ourselves a short break from work. Our employees showcased their artistic sides with colorful rangolis, adding a picturesque view to our office. To spice things up, we planned games and fun activities to charge ourselves for the event. As an element of surprise🎁, we had a few announcements and awards distribution to commemorate our industrious employees. In the evening, we organized a Puja to thank the almighty lord for keeping us motivated throughout the year.  We called the day off with a scrumptious dinner! #diwalicelebrations #diwalidelights #festival #celebration #rangoli #awards #octavusfamily #octavusconsulting

𝐈𝐧 𝟐𝟎𝟐𝟑, 𝐭𝐡𝐞 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟒𝟔.𝟓𝐁 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟔𝟗.𝟔𝐁 𝐛𝐲 𝟐𝟎𝟑𝟐 𝐬𝐡𝐨𝐰𝐜𝐚𝐬𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟓% With the growing prevalence of chronic gastrointestinal conditions owing to poor dietary habits and lifestyle choices, biopharma companies have come to the rescue with innovative therapies and an unyielding pursuit of delivering care globally. Several biopharma companies have entered into collaborations with gastro-focused companies to expand their portfolios.  As a closing note to our Gastroenterology theme, Octavus Consulting brings an interesting analysis of the most prominent deal in the gastro domain.  𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝘂𝘀 𝗮𝘁 𝗯𝗱@𝗼𝗰𝘁𝗮𝘃𝘂𝘀𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗶𝗻𝗴.𝗰𝗼𝗺 𝗳𝗼𝗿: 𝟭. 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗖𝗮𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝟮. 𝗗𝗲𝗲𝗽 𝗗𝗶𝘃𝗲 𝗗𝗲𝗮𝗹𝘀 𝗔𝗻𝗮𝗹𝘆𝘀𝗲𝘀 𝟯. 𝗖𝘂𝗿𝗮𝘁𝗲𝗱 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝟰. 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀/𝗔𝘀𝘀𝗲𝘁𝘀 𝗔𝗻𝗮𝗹𝘆𝘀𝗲𝘀 𝟱. 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝗗𝘂𝗲 𝗗𝗶𝗹𝗶𝗴𝗲𝗻𝗰𝗲 Novartis #gastroenterology #gastrointestinal #prominentdeal #acquisition #dealanalysis #investorrelation #milestone #financereport #octavusconsulting

As Diwali approaches, the excitement of shopping for gifts and festive essentials fills the air. But have you ever wondered what really influences your choices during this vibrant season? Let’s explore the key factors that shape our purchasing decisions: • 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐏𝐚𝐜𝐤𝐚𝐠𝐢𝐧𝐠 𝐚𝐧𝐝 𝐀𝐞𝐬𝐭𝐡𝐞𝐭𝐢𝐜𝐬: In a sea of options, do you find yourself drawn to beautifully designed packaging? The visual appeal can create a lasting impression and enhance the festive spirit. • 𝐁𝐫𝐚𝐧𝐝 𝐑𝐞𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐓𝐫𝐮𝐬𝐭: How much does a brand’s history and credibility impact your buying decisions? Trust in a brand can make all the difference, especially when choosing gifts for loved ones. • 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐕𝐚𝐥𝐮𝐞 𝐟𝐨𝐫 𝐌𝐨𝐧𝐞𝐲: Are you a practical shopper who prioritizes quality and value? Finding products that offer great functionality at a reasonable price is essential during the festive rush. • 𝐄𝐦𝐨𝐭𝐢𝐨𝐧𝐚𝐥 𝐀𝐩𝐩𝐞𝐚𝐥 𝐚𝐧𝐝 𝐒𝐭𝐨𝐫𝐲𝐭𝐞𝐥𝐥𝐢𝐧𝐠: Do you connect with brands that share heartfelt stories or values that resonate with you? Emotional connections can drive loyalty and influence your choices in a meaningful way. Each factor adds depth to our shopping experience, making it unique and personal. As you prepare for this Diwali, think about what influences your decisions the most. Do you prioritize aesthetics, trust, functionality, or emotional connection? Share your insights with Octavus Consulting!

𝐔𝐄𝐆𝐖 𝟐𝟎𝟐𝟒: 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 Octavus Consulting! Get insights from the recently held, UEGW 2024 conference with your trusted intelligence partner Octavus Consulting! Ranging from innovative therapies in gastroenterology to enlightening data, here’s a glimpse of key abstracts presented at the illuminating conference: • ELEVATE UC 52 & ELEVATE UC 12 Studies from Pfizer -Ulcerative Colitis • True North Study from Bristol Myers Squibb -Ulcerative Colitis • VIVID-1 Study from Eli Lilly and Company -Crohn’s Disease •  U-ACTIVATE Study from AbbVie -Ulcerative Colitis Contact us at bd@octavusconsulting.com for a custom conference coverage report. #UEGW2024 #gastroenterology #gastrointestinal #clinicaltrials #ulcerativecolitis #crohnsdisease #pharma #healthcareinnovation #pharmaceuticalindustry #biotechindustry #octavusconsulting

𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝟏𝟎 𝐦𝐨𝐬𝐭 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐭 𝐆𝐚𝐬𝐭𝐫𝐨𝐞𝐧𝐭𝐞𝐫𝐨𝐥𝐨𝐠𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬! In October, Octavus Consulting is tirelessly exploring Gastroenterology as a theme! Throughout the month, we kept you busy with interesting analyses of Gastroenterology indications. Today, we bring an illuminating post on the Top 10 Most Prevalent Gastrointestinal Diseases, shedding light on key details such as vulnerable gender, underlying causes, and provisional mortality reported in the US (2023) Contact us at bd@octavusconsulting.com for curated analyses of gastroenterology diseases, disease landscape, or conference coverage. #gastroenterologydiseases #gastrointestinal #mortality #vulnerablegender #underlyingcauses #provisionalmortality #octavusconsulting

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭-𝐬𝐨𝐥𝐝 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐝𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐆𝐚𝐬𝐭𝐫𝐨𝐞𝐧𝐭𝐞𝐫𝐨𝐥𝐨𝐠𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞? With Gastroenterology as a theme, Octavus Consulting is adamantly delivering engaging updates and key insights from the gastrointestinal domain! Contact us at bd@octavusconsulting.com for a curated analysis of gastroenterology diseases, the disease landscape, or conference coverage. Takeda AbbVie Ironwood Pharmaceuticals AstraZeneca Mallinckrodt Pharmaceuticals #entyvio #creon #linzess #nexium #voquezna #gattex #dexilant #protonix #amitizia #lialda #gastroenterology #gastrointestinal #top10 #prescriptiondrugs #octavusconsulting

🚀 𝐊𝐞𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐐𝟐 𝟐𝟎𝟐𝟒 𝐏𝐡𝐚𝐫𝐦𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐛𝐲 Octavus Consulting!  Pharma giants continue to showcase strong revenue growth driven by breakthrough therapies and regulatory milestones. Here are the major highlights:    📊 Top Performers:  👉 Johnson & Johnson: Robust growth in Pharmaceutical & MedTech sectors. Key wins include Nipocalimab and IMBRUVICA updates, plus the strategic acquisition of PROTEOLOGIX Inc.  👉 Roche: Impressive performance with advancements in STARGLO + GemOx for DLBCL and filings for ELEVIDYS and LUNSUMIO.  👉 @Merck & Co: Strong revenue from Oncology, Vaccines, and Diabetes portfolios, including positive results for KEYTRUDA and approvals for CAPVAXIVE and WINREVAIR.  👉 AbbVie: Gains in Immunology, Neuroscience, and Oncology. Notable results include RINVOQ for Giant Cell Arteritis and approvals for SKYRIZI and TEPKINLY.    🔍 Industry Trends to Watch:  💠 Surge in biosimilar competition.  💠Increasing M&A and partnerships, like AbbVie’s deal with Gilgamesh Pharmaceuticals.  💠Focus on innovative treatments in oncology, immunology, and neuroscience.  💠The pharma landscape continues to evolve with regulatory approvals, pipeline growth, and strategic collaborations driving industry momentum!    What are your thoughts on these shifts in the pharma industry?    Reach out to us at bd@octavusconsulting.com for:  1. Deep dive finance reports  2. Deals analysis  3. Curated Report on Investor Relations  4. Funding and Capital Investment Guidance  5. Financial Decision Making  Stay Tuned for more updates!  #Pharma #MedicalResearch #HealthcareInnovation #InvestorInsights #PharmaTrends #Biosimilars #DrugDevelopment #MergersAndAcquisitions #PharmaCI #Q22024 

𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 is a crucial strategy in marketing that involves dividing a broad target market into smaller, more manageable sub-groups of consumers with common needs, preferences, or characteristics. By identifying and understanding these segments, businesses can tailor their products, services, and marketing efforts to meet the specific needs of each group, resulting in more effective and efficient marketing. This approach not only enhances customer satisfaction but also 𝐡𝐞𝐥𝐩𝐬 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐦𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐭𝐡𝐞𝐢𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐚𝐜𝐡 𝐚𝐧𝐝 𝐩𝐫𝐨𝐟𝐢𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲. Key market segmentation methods include 𝐝𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜, 𝐠𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜, 𝐩𝐬𝐲𝐜𝐡𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜, 𝐚𝐧𝐝 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫𝐚𝐥 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧, each offering unique insights into consumer behavior and preferences. 𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧      𝟏. 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: Divides the market based on factors such as age, gender, income, and education  𝟐. 𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: Segments the market by location, including country, region, or city  𝟑. 𝐏𝐬𝐲𝐜𝐡𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: Focuses on lifestyle, values, interests, and personality traits  𝟒. 𝐁𝐞𝐡𝐚𝐯𝐢𝐨𝐫𝐚𝐥 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: Based on consumer behaviors, such as purchasing habits and brand loyalty  Octavus Consulting offers expert market segmentation services using advanced techniques to enhance research outcomes. Our team uses in-depth data analysis to define customer segments, enabling targeted marketing, optimized resource use, and improved ROI. Whether entering new markets or strengthening current ones, our tailored solutions ensure your marketing efforts effectively reach and resonate with the right audience.    For more details, reach out to us at bd@octavusconsulting.com #marketsegmentation #marketresearch #demographicsegmentation #geographicsegmentation #psychographicsegmentation #behavioralsegmentation #consulting #octavusconsulting

𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐭𝐫𝐢𝐮𝐦𝐩𝐡 𝐨𝐟 𝐠𝐨𝐨𝐝 𝐨𝐯𝐞𝐫 𝐞𝐯𝐢𝐥 𝐰𝐢𝐭𝐡 Octavus Consulting! Octavus Consulting wishes you a very happy Dussehra! Let your actions and decisions embody the righteousness and virtuousness of Lord Rama! #vijaydashmi #festival #celebration #dussehra #octavusconsulting

𝐈𝐧 𝐎𝐜𝐭𝐨𝐛𝐞𝐫, Octavus Consulting, 𝐢𝐬 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐆𝐚𝐬𝐭𝐫𝐨𝐞𝐧𝐭𝐞𝐫𝐨𝐥𝐨𝐠𝐲 𝐚𝐬 𝐚 𝐭𝐡𝐞𝐦𝐞! This week we will examine Gastroparesis' Competitor's Landscape. 𝐆𝐚𝐬𝐭𝐫𝐨𝐩𝐚𝐫𝐞𝐬𝐢𝐬 𝐚𝐤𝐚 𝐝𝐞𝐥𝐚𝐲𝐞𝐝 𝐠𝐚𝐬𝐭𝐫𝐢𝐜 𝐞𝐦𝐩𝐭𝐲𝐢𝐧𝐠 𝐢𝐬 𝐜𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐳𝐞𝐝 𝐛𝐲 𝐬𝐥𝐨𝐰 𝐦𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐟𝐨𝐨𝐝 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐬𝐭𝐨𝐦𝐚𝐜𝐡 𝐭𝐨 𝐭𝐡𝐞 𝐬𝐦𝐚𝐥𝐥 𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐞. Draw insights from our meticulously prepared competitive landscape with a glimpse of assets from several biopharma companies working in Gastroparesis. Our competitive landscape service provides comprehensive competitor mapping to keep you ahead of the curve all the time. With our thorough portfolio assessment, we keep you up-to-date on competitors' pipeline candidates and marketed products. Moreover, our competitive landscape offering includes a trend assessment to help understand the ever-evolving healthcare market. Open the doors to endless opportunities and growth by reaching out to us at bd@octavusconsulting.com   #competitivelandscape #cl #gastroenterology #gastrointestinal #pcd #pipelinecandidates #biopharma #biotechnology #octavusconsulting